Avolta AG (DFRYF)

Oncternal Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 11, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,141	5,786	5,971	3,781	4,496	5,042
Market Cap Growth	34.40%	-3.10%	57.93%	-15.91%	-10.82%	9.61%
Enterprise Value	21,732	18,243	14,428	10,568	13,243	15,380
Last Close Price	52.00	41.61	38.38	40.52	47.30	64.06
PE Ratio	54.87	50.91	57.80	60.07	-	-
PS Ratio	0.46	0.38	0.39	0.51	1.05	1.74
PB Ratio	3.31	2.08	2.02	3.62	3.96	4.86
P/FCF Ratio	2.73	2.42	2.57	2.47	6.79	-
P/OCF Ratio	2.29	2.01	2.13	2.31	6.04	-
EV/Sales Ratio	1.25	1.20	0.95	1.42	3.08	5.31
EV/EBITDA Ratio	5.92	10.25	8.51	13.61	-	-
EV/EBIT Ratio	16.34	16.56	13.85	22.96	-	-
EV/FCF Ratio	7.28	7.61	6.21	6.91	19.99	-
Debt / Equity Ratio	6.00	4.73	4.49	6.81	7.21	9.94
Debt / EBITDA Ratio	3.98	4.28	4.45	4.28	12.88	195.39
Debt / FCF Ratio	4.95	5.49	5.73	4.65	12.34	-
Asset Turnover	0.82	0.81	0.99	0.71	0.37	0.21
Inventory Turnover	4.13	4.38	4.92	3.37	2.58	1.45
Quick Ratio	0.44	0.30	0.28	0.44	0.46	0.24
Current Ratio	0.77	0.69	0.60	0.91	0.88	0.62
Return on Equity (ROE)	12.14%	10.37%	12.48%	12.06%	-37.41%	-136.14%
Return on Assets (ROA)	3.90%	3.68%	4.25%	2.76%	-3.72%	-8.14%
Return on Capital (ROIC)	4.72%	4.44%	5.16%	3.32%	-4.26%	-9.44%
Return on Capital Employed (ROCE)	8.40%	7.50%	7.10%	6.30%	-	-
Earnings Yield	1.82%	1.96%	1.73%	1.67%	-9.40%	-56.35%
FCF Yield	36.65%	41.40%	38.88%	40.45%	14.73%	-10.01%
Dividend Yield	2.30%	2.65%	2.17%	-	-	-
Payout Ratio	121.19%	100.97%	-	-	-	-
Buyback Yield / Dilution	13.02%	-7.87%	-48.24%	-7.09%	-50.19%	-17.17%
Total Shareholder Return	15.32%	-5.22%	-46.07%	-7.09%	-50.19%	-17.17%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.